tiprankstipranks
OncoCyte Corp (OCX)
NASDAQ:OCX
US Market

OncoCyte (OCX) Income Statement

Compare
422 Followers

OncoCyte Income Statement

Last quarter (Q3 2024), OncoCyte's total revenue was $115.00K, a decrease of -73.19% from the same quarter last year. In Q3, OncoCyte's net income was $-13.49M. See OncoCyte’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.50M$ 958.00K$ 7.73M$ 1.22M$ 0.00
Gross Profit
$ 413.00K$ -18.00K$ 188.00K$ -639.00K$ -344.00K
Operating Expenses
$ 25.64M$ 30.31M$ 47.13M$ 33.08M$ 22.24M
Depreciation and Amortization
$ 1.68M$ 5.22M$ 4.21M$ 394.00K$ 344.00K
EBITDA
$ -23.12M$ -13.31M$ -48.46M$ -30.54M$ -21.89M
Operating Income
$ -25.14M$ -18.00M$ -46.95M$ -29.71M$ -22.24M
Other Income/Expenses
$ 281.00K$ -615.00K$ 854.00K$ -1.48M$ -187.00K
Pretax Income
$ -24.86M$ -18.61M$ -73.36M$ -31.19M$ -22.43M
Net Income
$ -27.78M$ -73.44M$ -64.10M$ -29.93M$ -22.33M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.75$ -13.26$ -14.42$ -9.14$ -8.71
Diluted EPS
$ -3.75$ -13.26$ -14.42$ -9.14$ -8.71
Weighted Average Shares Outstanding
7.65M 5.54M 4.45M 3.27M 2.56M
Weighted Average Shares Outstanding (Diluted)
7.65M 5.54M 4.45M 3.27M 2.56M
Currency in USD

OncoCyte Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis